Skip to main content
Signal8

BINDLEY WILLIAM E

SEC insider (Form 3/4/5 filer). CIK 0000903539. Director & 10% Owner at Guardian Pharmacy Services, Inc. (GRDN). 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 27, 2026. Located in ATLANTA, GA.

Companies BINDLEY WILLIAM E has filed insider reports for

  • Guardian Pharmacy Services, Inc. (GRDN): Director, 10% Owner
BINDLEY WILLIAM E profile photo

BINDLEY WILLIAM E

CIK: 0000903539

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (42.9%)

Position reduction

Option Exercises (M)3 (42.9%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Guardian Pharmacy Services, Inc. logo
GRDN

Guardian Pharmacy Services, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Guardian Pharmacy Services, Inc. logo
    GRDN

    Guardian Pharmacy Services, Inc.

    Sep 27, 2026
    Exercise
    Indirect
    6.1M shares-
  • Guardian Pharmacy Services, Inc. logo
    GRDN

    Guardian Pharmacy Services, Inc.

    Mar 20, 2026
    Sale
    Indirect
    3.6M shares at avg. $29.68$106.0M
  • Guardian Pharmacy Services, Inc. logo
    GRDN

    Guardian Pharmacy Services, Inc.

    Sep 27, 2025
    Exercise
    Indirect
    6.1M shares-
  • Guardian Pharmacy Services, Inc. logo
    GRDN

    Guardian Pharmacy Services, Inc.

    May 28, 2025
    Sale
    Indirect
    651.5K shares at avg. $20.16$13.1M
  • Guardian Pharmacy Services, Inc. logo
    GRDN

    Guardian Pharmacy Services, Inc.

    May 27, 2025
    Sale
    Indirect
    3.5M shares at avg. $20.16$70.7M
  • Guardian Pharmacy Services, Inc. logo
    GRDN

    Guardian Pharmacy Services, Inc.

    Mar 28, 2025
    Exercise
    Indirect
    6.1M shares-
  • Guardian Pharmacy Services, Inc. logo
    GRDN

    Guardian Pharmacy Services, Inc.

    Sep 27, 2024
    Award

    Class B Common Stock

    Indirect
    24.4M shares-

1-7 of 7